XBIT
XBiotech Inc.Company Information
- Company Name
- XBiotech Inc.
- CIK
- CIK0001626878
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- XBIT: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- XBIT
SEC filing data through
Insider Sentiment
- Last purchase
- 2019-06-04
- Last sale
- 2021-10-18
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 1,914,951
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 1,950,483
- Shares outstanding
- 30,487,731
- Ownership
- 6.40%
Earnings Market Reaction
- Filing date
- 2026-08-13
- Price on filing date
- —
- 1-month reaction
- -5.58%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents At Carrying Value | 110 | 115 | 126 | 147 | 153 | 156 | 173 | 183 | 189 | 201 | 200 | 202 | ||||||
| Accounts Receivable Net Current | - | - | - | 0 | 0 | 0 | - | 1 | 1 | 1 | - | 1 | ||||||
| Interest Receivable Current | 0 | 0 | 0 | - | - | - | 1 | - | - | - | 1 | - | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 111 | 117 | 127 | 149 | 155 | 158 | 175 | 185 | 191 | 203 | 202 | 204 | ||||||
| Short Term Investments | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Income Taxes Receivable | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense And Other Assets Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Property Plant And Equipment Net | 22 | 23 | 23 | 23 | 24 | 24 | 25 | 25 | 25 | 25 | 25 | 25 | ||||||
| Assets | 134 | 140 | 150 | 172 | 179 | 182 | 199 | 210 | 216 | 228 | 227 | 230 | ||||||
| Accounts Payable Current | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 2 | 2 | 3 | 3 | 1 | ||||||
| Accrued Liabilities Current | 2 | 2 | 6 | 2 | 2 | 4 | 3 | 4 | 5 | 4 | 4 | 4 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 3 | 3 | 8 | 4 | 4 | 5 | 15 | 16 | 17 | 17 | 6 | 5 | ||||||
| Accrued Income Taxes Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Convertible Debt Current | - | - | - | - | - | - | - | 10 | 10 | 10 | - | - | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Accrued Income Taxes Noncurrent | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Deferred Income Tax Liabilities Net | 0 | 0 | 0 | - | - | - | 0 | - | - | - | 0 | 0 | ||||||
| Liabilities | 5 | 5 | 10 | 5 | 6 | 7 | 17 | 18 | 19 | 19 | 8 | 7 | ||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 277 | 277 | 277 | 277 | 277 | 276 | 273 | 272 | 272 | 272 | 271 | 270 | ||||||
| Stockholders Equity | 128 | 135 | 140 | 167 | 173 | 175 | 182 | 192 | 197 | 209 | 219 | 223 | ||||||
| Retained Earnings Accumulated Deficit | -149 | -142 | -136 | -109 | -103 | -102 | -91 | -80 | -75 | -62 | -52 | -48 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Liabilities And Stockholders Equity | 134 | 140 | 150 | 172 | 179 | 182 | 199 | 210 | 216 | 228 | 227 | 230 | ||||||
| Preferred Stock No Par Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock No Par Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Shares Outstanding | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | ||||||
| Common Stock Shares Issued | 30 | 30 | 30 | 30 | - | - | 30 | - | - | - | 30 | 30 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialXBiotech Inc. (XBIT) — SEC Financial Statements & Analysis
XBiotech Inc. (XBIT) is a pharmaceutical preparations company, incorporated in A1. XBiotech Inc. trades on Nasdaq as: XBIT. XBiotech Inc. (XBIT)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, XBiotech Inc. carries a market cap of $70.12M, a P/E ratio of -1.55x, a P/B ratio of 0.55x, a P/S ratio of 418.00x, an enterprise value of $-39.41M, and an EV/EBITDA multiple of 0.84x. On profitability, it posts an operating margin of -12361.67%, a net margin of -7708.33%, a Return on Equity (ROE) of -29.94%, a Return on Assets (ROA) of -28.90%, and a Return on Invested Capital (ROIC) of -245.40%. Per share, it reports EPS of $-1.48, diluted EPS of $-1.49, free cash flow per share of $-1.34, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of 60.26% year-over-year, and EPS growth of 60.26% year-over-year. On the balance sheet, it maintains a current ratio of 33.15x, a quick ratio of 32.75x, working capital of $107.81M, a debt-to-equity ratio of 0.04x, a debt ratio of 0.04, an interest coverage ratio of -632.78x, free cash flow of $-40.84M (TTM), and net debt of $-109.53M. Figures sourced from SEC EDGAR.
- Market Cap
- $70.12M
- P/E TTM
- -1.55x
- EPS TTM
- $-1.48
- P/B TTM
- 0.55x
- ROE TTM
- -29.94%
- ROA TTM
- -28.90%
- Debt To Equity
- 0.04x
- Free Cash Flow TTM
- $-40.84M
- Net Revenue TTM Growth 1Y
- -100.00%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is XBiotech Inc. in?
XBiotech Inc. (XBIT) operates in the Pharmaceutical Preparations industry.
What exchange does XBIT trade on?
XBiotech Inc. (XBIT) trades on the Nasdaq.
Where is XBiotech Inc. incorporated?
XBiotech Inc. is incorporated in British Columbia, Canada.
When was XBiotech Inc. (XBIT)'s most recent SEC filing?
XBiotech Inc. (XBIT)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13.
What is XBIT's market cap?
XBiotech Inc. (XBIT) has a market capitalization of $70.12M as of 2026-06-30.
What is XBIT's EPS (earnings per share)?
XBiotech Inc. (XBIT)'s trailing twelve month EPS is $-1.48 as of 2026-06-30.
What is XBIT's ROE (return on equity)?
XBiotech Inc. (XBIT)'s trailing twelve month Return on Equity (ROE) is -29.94% as of 2026-06-30.
What is XBIT's ROA (return on assets)?
XBiotech Inc. (XBIT)'s trailing twelve month Return on Assets (ROA) is -28.90% as of 2026-06-30.
What is XBIT's ROIC (return on invested capital)?
XBiotech Inc. (XBIT)'s trailing twelve month Return on Invested Capital (ROIC) is -245.40% as of 2026-06-30.
What is XBIT's EV/EBITDA?
XBiotech Inc. (XBIT)'s trailing twelve month EV/EBITDA is 0.84x as of 2026-06-30.